玻璃体切割联合术治疗增殖型糖尿病视网膜病变

目的: 探讨玻璃体切割联合手术治疗增殖型糖尿病视网膜病变Ⅳ～Ⅵ期的临床效果.方法: 对41例(48眼)增殖型糖尿病视网膜病变患者采用闭合式玻璃体切割联合剥膜、广泛眼内光凝术、气液交换、硅油填充、玻璃体腔内注射曲安奈德手术治疗.结果: 术后41只眼视力均有不同程度提高,占85.41%,4只眼视力术后无变化,占8.33%,3只眼术后视力较术前视力略下降,占6.25%.随访时间为1～24个月,手术并发症少.结论:闭合式玻璃体切割联合剥膜、广泛眼内光凝术、气液交换、硅油填充、玻璃体腔内注射曲安奈德手术治疗增殖型糖尿病视网膜病变Ⅳ～Ⅵ期患者,疗效良好.

Vitrectomy combined other surgeries in the treatment of proliferative diabetic retinopathy

Objective: To evaluate the surgical effects of pars plana vitrectomy combined other surgeries for proliferative diabetic retinophaty(PDR). Methods: Forty-one cases(48 eyes) with PDR were operated in vitrectomy combined with retinal photocoagulation, stripping of membrane, silicon oil filling, exchange of gas and fluid,intravitreal triamcinolone acetonide injection. Results: All of the cases were performed vitrectomy successfully. The final visual acuity got improved in 41 eyes (85. 41%). The patients were followed up for 1-24 months after surgery. Conclusion:Vitrecomy combined other surgeries is an effective treatment for PDR.